Publications by Dr Bridget Wilkins - ePrints

Browsing publications by Dr Bridget Wilkins.

Newcastle Authors	Title	Year
Dr Kevin Windebank Dr Bridget Wilkins	Post Cardiac Transplantation Lymphoproliferative Disorder Presenting as t(8;14) Burkitt Leukaemia/Lymphoma Treated With Low Intensity Chemotherapy and Rituximab	2009
Dr Uma Nath Dr Valerie Wilson Dr Bridget Wilkins	FIP1L1-PDGFRA positive chronic eosinophilic leukaemia and associated central nervous system involvement	2008
Dr Bridget Wilkins	Bone marrow pathology in essential thrombocythemia: Interobserver reliability and utility for identifying disease subtypes	2008
Elizabeth Matheson Mike Cole Dr Bridget Wilkins Dr Andrew Hall	Mismatch repair defects in childhood acute lymphoblastic leukaemia at diagnosis and relapse	2008
Dr Rachel Crossland Dr Christine Challen Dr Bridget Wilkins Dr Stephen Crosier Dr John Anderson et al.	Definitive identification of the Val617Phe mutation in myeloproliferative disorders using Real Time PCR utilising Roche Lightcycler/hybriprobe technology	2007
Professor Muzlifah Haniffa Dr Bridget Wilkins Dr Nicholas Simpson	Cutaneous extramedullary hemopoiesis in chronic myeloproliferative and myelodysplastic disorders	2006
Dr David Milligan Dr Bridget Wilkins	Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study	2005
Adillah Binti Yusof Dr Kelli Ryan Dr Bridget Wilkins	Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis	2005
Dr Bridget Wilkins	Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia	2005
Dr Bridget Wilkins	JAK2 V617F mutation identifies a biologically distinct subtype of essential thrombocythemia which resembles polycythemia vera	2005
Sarina Sulong Marian Case Lynne Minto Dr Bridget Wilkins Dr Andrew Hall et al.	The V617F mutation in Jak2 is not found in childhood acute lymphoblastic leukaemia	2005
Dr Bridget Wilkins	Current Diagnostic Pathology: Foreword	2004
Dr Bridget Wilkins	Loss of heterozygosity at chromosome 9p2 I is a frequent finding in enteropathy-type T-cell lymphoma	2004
Ajay Gupta Dr Brian Shenton Muhammed Gok John Asher Dr Bridget Wilkins et al.	Plasma cell myeloma variant of post-transplant lymphoproliferative disorder in a solid organ transplant recipient: a case report	2004
Dr Bridget Wilkins Dr Joseph Reilly	The medical research council PT1 trial in essential thrombocythemia	2004
Dr Bridget Wilkins	Unusual splenic sinusoidal iron overload in sickle cell/haemoglobin D-Punjab disease	2004
Dr Bridget Wilkins	Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction	2003
Dr Bridget Wilkins	Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma	2003
Dr Bridget Wilkins	Self-assessment: Bone marrow pathology	2003
Dr Bridget Wilkins	Splenic marginal zone atrophy and progressive CD8+T-cell lymphocytosis in HIV infection: a study of adult post-mortem spleens from Cote d'Ivoire	2003
Dr Bridget Wilkins	A single-centre study of treatment outcomes and survival in 120 patients with peripheral T-cell non-Hodgkin's lymphoma	2002
Dr Bridget Wilkins	Teaching cases from the Royal Marsden and St Mary's Hospitals. Case 23: an unexpected finding during investigation of thrombocytopenia	2002
Dr Bridget Wilkins	The spleen	2002
Dr Bridget Wilkins	The spleen	2002
Dr Bridget Wilkins	Fatal disseminated fusarium infection in acute lymphoblastic leukaemia in complete remission	2001
Dr Paul Sinclair Dr Bridget Wilkins	Identification of four new translocations involving FGFR1 in myeloid disorders	2001
Professor David Ellison Dr Bridget Wilkins	Lymphoma and the nervous system	2001
Dr Bridget Wilkins	Tryptase-positive mast cells accompany lymphocytic as well as lymphoplasmacytic lymphoma infiltrates in bone marrow trephine biopsies	2001
Dr Bridget Wilkins	A new in vivo and in vitro B cell lymphoma model, pi-BCL1	2000
Neelam Varma Dr Bridget Wilkins	Acute myeloblastic leukaemia with differentiation to myeloblasts and mast cell blasts	2000
Dr Bridget Wilkins	Amplification of PCR products in excess of 600 base pairs using DNA extracted from decalcified, paraffin wax embedded bone marrow trephine biopsies	2000
Dr Bridget Wilkins	Formic acid decalcification of bone marrow trephines degrades DNA: alternative use of EDTA allows the amplification and sequencing of relatively long PCR products	2000
Sheila Morgan Dr Bridget Wilkins	Hepatic stellate cells express the low affinity nerve growth factor receptor p75 and undergo apoptosis in response to nerve growth factor stimulation	2000
Dr Brian Angus Dr Bridget Wilkins	Molecular analysis reveals somatically mutated and unmutated clonal and oligoclonal B cells in T-cell-rich B-cell lymphoma	2000
Dr Bridget Wilkins	Selective genetic analysis of p53 immunostain positive cells	2000